Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Adults with thymidine kinase 2 deficiency (TK2D) often look healthy until a stressor — like the flu or surgery — unmasks the disease. Experts highlight that late-onset TK2D has a distinct clinical profile, with symptoms like ptosis, facial weakness, and respiratory issues. A genetic diagnosis not only validates patients' long-misunderstood struggles but also opens the door to approved, dedicated therapy.
Thymidine kinase 2 deficiency (TK2D) doesn't always show up in childhood — and for adults living with the late-onset form, the journey to diagnosis can be long and frustrating. Experts Dr. Michio Hirano and Dr. Zarazuela Zolkipli-Cunningham discuss how adults with TK2D may appear perfectly healthy until a stressor like influenza or surgery triggers more pronounced symptoms, making the condition easy to miss or misattribute — sometimes even to psychogenic causes.
The late-onset phenotype is distinct: rather than the floppy infants or children losing milestones seen in early-onset TK2D, adults may present with ptosis, restricted eye movements, facial and bulbar weakness, low muscle bulk, and both proximal and distal weakness. Respiratory impairment requiring ventilatory support is also more likely in this group.
Key Takeaways:
Why it matters: Many adult TK2D patients have spent years being told their limitations aren't real. A confirmed genetic diagnosis reframes their experience, empowers them in daily life, and connects them to targeted treatment — making early recognition and comprehensive monitoring essential.